文献速递颅颌面外科

唇裂与腭裂修复术后阿片类药物处方与使用趋势的机构研究

Institutional Trends in Opioid Prescribing and Utilization after Primary Cleft Lip and Palate Repair.
PubMed 文献 · Plast Reconstr Surg · 2022-07-29

该前瞻性队列研究纳入2018年4月至2019年7月在某大型学术中心接受唇裂与腭裂修复术的59名儿童,分析术后阿片类药物处方模式与疼痛控制情况。结果显示90%患者出院时获阿片类药物处方,平均10剂,76%照护者给药少于处方量,疼痛控制与阿片类药物数量无关联(p=0.68)。作者建议将处方限制为3天用量以减少社区阿片类药物存量。

要点

  • 90%患儿出院时获阿片类药物处方,平均10剂(四分位距5-15剂)。
  • 76%照护者给药少于处方量,疼痛控制与阿片类药物数量无关联(p=0.68)。
  • 作者建议将处方限制为3天用量以减少社区阿片类药物可及量。

核心结论

  • 唇裂与腭裂修复术后阿片类药物常被过度处方。
  • 作者建议提供者考虑将处方限制为3天用量,以帮助减少社区中可获得的阿片类药物数量。

研究设计与样本

  • 前瞻性队列研究,纳入2018年4月至2019年7月在某大型学术中心接受唇裂与腭裂修复术的儿童,筛查后共59名儿童纳入研究。

主要发现

  • 患者中55.8%为男性,中位年龄12个月(四分位距5-15个月)。
  • 90%患者在出院时获得阿片类药物处方,平均剂量为10剂(四分位距5-15剂)。
  • 97%的照护者使用了辅助药物;阿片类药物给药中位时间为3天(四分位距2-6.5天)。
  • 76%的照护者给予的阿片类药物少于处方量;疼痛控制与阿片类药物数量之间无关联(p=0.68)。
  • 24%的照护者使用带锁储存;34%有剩余药物的受访者报告进行了处置。

临床怎么用

  • 作者建议提供者考虑将阿片类药物处方限制为3天用量,以帮助减少社区中可获得的阿片类药物数量。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Outpatient prescriptions for postoperative pain play an important role in the opioid epidemic. Prescribing guidelines are an effective target for intervention but require procedure-specific data to be successful. The aim of this study was to examine opioid prescribing patterns and pain control after primary cleft lip and palate repair at a large academic center. METHODS: Children undergoing cleft lip and palate repair from April of 2018 to July of 2019 were included in a prospective cohort study. Data on discharge prescriptions, refills, and emergency room visits were obtained from the medical record. Caregivers were surveyed 7 to 21 days after surgery regarding pain control, opioid use, education exposure, storage, and disposal. Chi-square tests and one-way analysis of variance were used to examine predictors of pain control, opioid consumption, safe storage, and disposal. RESULTS: After screening, 59 children were included in the study. Patients were 55.8 percent male with a median age of 12 months (interquartile range, 5 to 15). Ninety percent of patients received an opioid prescription at discharge with a mean quantity of 10 doses (interquartile range, 5 to 15). Ninety-seven percent of caregivers used adjunct medication. Opioids were given for a median of 3 days (interquartile range, 2 to 6.5). Seventy-six percent of caregivers gave less opioid than prescribed. There was no association between pain control and opioid quantity ( p = 0.68). Twenty-four percent of caregivers used locked storage. Thirty-four percent of respondents with leftover medication reported disposal. CONCLUSIONS: Opioids are often overprescribed after cleft lip and palate repair. Providers should consider limiting prescriptions to a 3-day supply to help reduce the quantity of opioids available in the community.

来源:Plast Reconstr Surg,查看原文。版权归原作者所有。

引用

  1. Sacks GN, Makar KG, Harbaugh CM, et al. Institutional Trends in Opioid Prescribing and Utilization after Primary Cleft Lip and Palate Repair. Plast Reconstr Surg. 2022. PMID: 35921649. doi:10.1097/PRS.0000000000009498

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。